NDAORALSYRUPPriority Review
Approved
Sep 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Priority Review
FLUMADINE (rimantadine hydrochloride) by Forest Devices is mechanism of action the mechanism of action of rimantadine is not fully understood. First approved in 1993.
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLUMADINE (rimantadine hydrochloride) is an oral antiviral syrup approved in 1993 for the treatment and prevention of influenza A virus infection. It works by inhibiting viral uncoating early in the replication cycle, with efficacy linked to the viral M2 protein. The drug represents one of the earliest FDA-approved neuraminidase inhibitor alternatives in oral form.
LOE Approaching
As LOE approaches, the brand team is likely contracting; career opportunities focus on managed decline, generic transition planning, and potential repositioning in niche prophylaxis segments.
Mechanism of Action
Mechanism of Action The mechanism of action of rimantadine is not fully understood. Rimantadine appears to exert its inhibitory effect early in the viral replicative cycle, possibly inhibiting the uncoating of the virus. Genetic studies suggest that a virus protein specified by the virion M 2 gene…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FLUMADINE offers limited growth potential; this is a defensive career position suited to professionals managing mature/declining assets or transitioning to emerging products. Roles focus on protecting market share against generics, managing payer relationships, and planning for product life-cycle conclusion.
Brand Manager
Worked on FLUMADINE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.